| Literature DB >> 35042905 |
Guan Fan1, Zhiyuan Jiang1, Jianling Li1, Liu Shi1, Chun Gui2,3,4, Rongjie Huang5,6,7.
Abstract
Hypertension (HTN) is getting more prevalent in China, but the HTN's status in Guangxi remains unclear. Our study started from 2013 to 2015 and was dedicated to better acknowledging the status of HTN in Guangxi. The study enrolled 17,100 residents aged ≥ 15 years across Guangxi, from 2013 to 2015, using a stratified multistage random sampling method. Parameters including blood pressure (BP), height, and weight were measured by validated devices. HTN was defined as the average systolic BP (SBP) ≥ 140 mm Hg and/or average diastolic BP (DBP) ≥ 90 mm Hg, or any usage of antihypertensive medications within two weeks. The awareness, treatment, and control were defined as a self-reported history of HTN, a self-reported current usage of antihypertensive medications, and a BP lower than 140/90 mm Hg, respectively. The age and sex-standardized prevalence, awareness, treatment, control rates of HTN for the population aged ≥ 15 years in Guangxi were 15.80%, 16.48%, 11.99%, 3.62%, respectively. Prevalence and control rates were the same for men and women (P > 0.05), while women's awareness and treatment rates were higher than those of men (P < 0.05). Zhuang nationality had a higher prevalence than Han (23.50% vs. 20.35%, P < 0.001), while Han had higher awareness, treatment, control rates (37.39% vs. 31.22%, 30.59% vs. 22.37%, 8.99% vs. 4.55%, individually, P < 0.05). HTN was prevalent in Guangxi, while the awareness, treatment, control rates were adverse. Region-specific strategies to intervene in HTN were needed.Entities:
Mesh:
Year: 2022 PMID: 35042905 PMCID: PMC8766488 DOI: 10.1038/s41598-021-04735-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Characteristics of study group by sex and ethnicity.
| Characteristics | Total | Ethnicity | Sex | |||||
|---|---|---|---|---|---|---|---|---|
| Han | Zhuang | Others | Men | Women | ||||
| N (%) | 13,813 (100%) | 6506 (47.1%) | 6923 (50.1%) | 384 (2.8%) | 6512 (47.1%) | 7301 (52.9%) | ||
| Mean age (years) | 46.87 ± 19.24 | 46.78 ± 18.99 | 47.43 ± 19.41 | 38.30 ± 18.47 | 0.051 | 46.05 ± 19.30 | 47.6 ± 19.17 | < 0.001 |
| Never attended school | 1628 (11.8%) | 683 (10.5%) | 926 (13.4%) | 19 (4.9%) | < 0.001 | 351 (5.4%) | 1277 (17.6%) | < 0.001 |
| Elementary school | 4245 (30.8%) | 1930 (29.7%) | 2162 (31.4%) | 153 (39.8%) | 1982 (30.5%) | 2263 (31.1%) | ||
| Elementary middle school | 5895 (42.8%) | 2909 (44.8%) | 2793 (40.5%) | 193 (50.3%) | 3062 (47.1%) | 2833 (38.9%) | ||
| High school or above | 2007 (14.6%) | 977 (15.0%) | 1011 (14.7%) | 19 (4.9%) | 1106 (17.0%) | 901 (12.4%) | ||
| Height (cm) | 158.11 ± 8.62 | 159.03 ± 8.72 | 157.41 ± 8.47 | 155.03 ± 7.61 | < 0.001 | 164.16 ± 6.57 | 152.7 ± 6.33 | < 0.001 |
| Weight (kg) | 55.85 ± 9.69 | 57.06 ± 9.56 | 54.85 ± 9.68 | 53.38 ± 9.56 | < 0.001 | 60.27 ± 9.13 | 51.9 ± 8.39 | < 0.001 |
| Mean BMI, kg/m2 | 22.29 ± 3.18 | 22.52 ± 3.14 | 22.08 ± 3.18 | 22.18 ± 3.48 | < 0.001 | 22.35 ± 3.08 | 22.24 ± 3.26 | 0.058 |
| Overweight or obesity: BMI ≥ 24 kg/m2, n (%) | 3603 (26.1%) | 1908 (29.3%) | 1601 (23.1%) | 94 (24.5%) | < 0.001 | 1757 (27.0%) | 1846 (25.3%) | 0.023 |
| Overweight: 24 ≤ BMI < 28 kg/m2, n (%) | 2981 (21.6%) | 1599 (24.6%) | 1311 (18.9%) | 71 (18.5%) | 1524 (23.4%) | 1457 (20.0%) | ||
| Obesity: BMI ≥ 28 kg/m2, n (%) | 622 (4.5%) | 309 (4.7%) | 290 (4.2%) | 23 (6.0%) | 233 (3.6%) | 389 (5.3%) | ||
| Family history of HTN, n (%) | 1185 (8.6%) | 726 (11.2%) | 439 (6.3%) | 20 (5.2%) | < 0.001 | 552 (8.5%) | 633 (8.7%) | 0.685 |
| Non-smokers | 11,522 (83.4%) | 5480 (84.2%) | 5714 (82.5%) | 328 (85.4%) | 0.002 | 4237 (65.1%) | 7285 (99.8%) | < 0.001 |
| Past smokers | 156 (1.1%) | 57 (0.9%) | 97 (1.4%) | 2 (0.5%) | 152 (2.3%) | 4 (0.1%) | ||
| Current smokers | 2135 (15.5%) | 969 (14.9%) | 1112 (16.1%) | 54 (14.1%) | 2123 (32.6%) | 12 (0.2%) | ||
| History of alcohol consumption, n (%) | 2196 (15.9%) | 1035 (15.9%) | 1106 (16.0%) | 55 (14.3%) | 0.915 | 2099 (32.2%) | 97 (1.3%) | < 0.001 |
HTN hypertension, BMI Body Mass Index.
Data are presented as n (%) or mean ± SD.
*Missing 38 cases.
Blood pressure and prevalence of HTN by characteristics.
| Characteristics | N | Blood Pressure (mmHg) | Hypertension classification, n (%) | prevalence of HTN, n (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| SBP | DBP | PP | Normal | Prehypertension | Stage 1 | Stage 2 | Stage 3 | |||
| Total | 13,813 | 126.77 ± 19.10 | 74.34 ± 9.76 | 52.43 ± 15.63 | 5193 (37.60%) | 5606 (40.58%) | 1851 (13.40%) | 750 (5.43%) | 220 (1.59%) | 3014 (21.82%) |
| 15–24 | 1787 | 115.87 ± 10.48 | 69.09 ± 7.60 | 46.79 ± 9.50 | 1137 (63.63%) | 603 (33.74%) | 45 (2.52%) | 2 (0.11%) | 0 (0.00%) | 47 (2.63%) |
| 25–34 | 2344 | 116.74 ± 10.49 | 72.23 ± 7.61 | 44.52 ± 9.05 | 1365 (58.23%) | 917 (39.12%) | 55 (2.35%) | 7 (0.30%) | 0 (0.00%) | 62 (2.65%) |
| 35–44 | 2606 | 119.97 ± 12.6 | 74.33 ± 8.12 | 45.65 ± 9.66 | 1178 (45.20%) | 1252 (48.04%) | 135 (5.18%) | 27 (1.04%) | 5 (0.19%) | 176 (6.75%) |
| 45–54 | 2171 | 126.46 ± 15.81 | 76.44 ± 9.86 | 50.02 ± 11.83 | 720 (33.16%) | 1016 (46.80%) | 322 (14.83%) | 71 (3.27%) | 13 (0.60%) | 435 (20.04%) |
| 55–64 | 1929 | 133.57 ± 19.47 | 77.02 ± 10.83 | 56.55 ± 15.07 | 430 (22.29%) | 815 (42.25%) | 439 (22.76%) | 158 (8.19%) | 35 (1.81%) | 684 (35.46%) |
| 65–74 | 1564 | 140.72 ± 21.44 | 76.47 ± 11.03 | 64.25 ± 17.53 | 224 (14.32%) | 556 (35.55%) | 439 (28.07%) | 220 (14.07%) | 69 (4.41%) | 784 (50.13%) |
| ≥ 75 | 1412 | 145.48 ± 22.67 | 75.23 ± 11.51 | 70.25 ± 19.26 | 139 (9.84%) | 447 (31.66%) | 416 (29.46%) | 265 (18.77%) | 98 (6.94%) | 826 (58.50%) |
| < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | ||||||
| Men | 6512 | 127.5 ± 18.22 | 75.56 ± 9.70 | 51.94 ± 14.71 | 2157 (33.12%) | 2943 (45.19%) | 894 (13.73%) | 334 (5.13%) | 101 (1.55%) | 1412 (21.68%) |
| Women | 7301 | 126.12 ± 19.84 | 73.24 ± 9.68 | 52.88 ± 16.40 | 3036 (41.58%) | 2663 (36.47%) | 957 (13.11%) | 416 (5.70%) | 119 (1.63%) | 1602 (21.94%) |
| < 0.001 | < 0.001 | < 0.001 | < 0.001 | 0.713 | ||||||
| Han | 6506 | 125.47 ± 18.29 | 74.98 ± 9.17 | 50.49 ± 15.21 | 2554 (39.26%) | 2628 (40.39%) | 823 (12.65%) | 295 (4.53%) | 87 (1.34%) | 1324 (20.35%) |
| Zhuang | 6923 | 128.21 ± 19.85 | 73.78 ± 10.22 | 54.43 ± 15.94 | 2467 (35.63%) | 2829 (40.86%) | 981 (14.17%) | 440 (6.36%) | 132 (1.91%) | 1627 (23.50%) |
| Others | 384 | 122.83 ± 16.68 | 73.5 ± 10.39 | 49.33 ± 12.12 | 172 (44.79%) | 149 (38.80%) | 47 (12.24%) | 15 (3.91%) | 1 (0.26%) | 63 (16.41%) |
| < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | ||||||
| < 24 | 10,210 | 124.7 ± 18.24 | 73.18 ± 9.3 | 51.51 ± 15.27 | 4312 (42.23%) | 4088 (40.04%) | 1128 (11.05%) | 436 (4.27%) | 139 (1.36%) | 1810 (17.73%) |
| ≥ 24 | 3603 | 132.65 ± 20.25 | 77.6 ± 10.28 | 55.05 ± 16.35 | 881 (24.45%) | 1518 (42.13%) | 723 (20.07%) | 314 (8.71%) | 81 (2.25%) | 1204 (33.42%) |
| < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | ||||||
| Never attended school | 1628 | 139.84 ± 22.34 | 75.21 ± 11.12 | 64.64 ± 18.95 | 275 (16.89%) | 572 (35.14%) | 418 (25.68%) | 237 (14.56%) | 75 (4.61%) | 781 (47.97%) |
| Elementary school | 4245 | 131.95 ± 20.4 | 75.83 ± 10.29 | 56.12 ± 16.88 | 1156 (27.23%) | 1750 (41.22%) | 822 (19.36%) | 334 (7.87%) | 101 (2.38%) | 1339 (31.54%) |
| Elementary middle school | 5895 | 121.79 ± 15.3 | 73.36 ± 9.13 | 48.43 ± 12.08 | 2688 (45.60%) | 2502 (42.44%) | 486 (8.24%) | 136 (2.31%) | 36 (0.61%) | 705 (11.96%) |
| High school or above | 2007 | 119.67 ± 14.47 | 73.35 ± 8.65 | 46.32 ± 10.88 | 1069 (53.26%) | 762 (37.97%) | 118 (5.88%) | 39 (1.94%) | 7 (0.35%) | 176 (8.77%) |
| < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | ||||||
| No family history | 12,628 | 126.73 ± 19.16 | 74.2 ± 9.71 | 52.53 ± 15.79 | 4758 (37.68%) | 5151 (40.79%) | 1667 (13.20%) | 689 (5.46%) | 210 (1.66%) | 2719 (21.53%) |
| Family history | 1185 | 127.17 ± 18.45 | 75.8 ± 10.19 | 51.37 ± 13.83 | 435 (36.71%) | 455 (38.40%) | 184 (15.53%) | 61 (5.15%) | 10 (0.84%) | 295 (24.89%) |
| 0.451 | < 0.001 | 0.006 | 0.51 | 0.007 | ||||||
| Non-smokers | 11,522 | 126.05 ± 18.95 | 73.89 ± 9.57 | 52.16 ± 15.61 | 4573 (39.69%) | 4545 (39.45%) | 1471 (12.77%) | 601 (5.22%) | 171 (1.48%) | 2404 (20.86%) |
| Past smokers | 156 | 140.69 ± 24.01 | 78.62 ± 12.20 | 62.07 ± 19.42 | 32 (20.51%) | 48 (30.77%) | 35 (22.44%) | 26 (16.67%) | 10 (6.41%) | 76 (48.72%) |
| Current smokers | 2135 | 129.65 ± 18.89 | 76.45 ± 10.20 | 53.20 ± 15.22 | 588 (27.54%) | 1013 (47.45%) | 345 (16.16%) | 123 (5.76%) | 39 (1.83%) | 534 (25.01%) |
| < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | ||||||
| No history of alcohol consumption | 11,617 | 126.09 ± 19.01 | 73.75 ± 9.56 | 52.34 ± 15.71 | 4612 (39.70%) | 4592 (39.53%) | 1480 (12.74%) | 596 (5.13%) | 180 (1.55%) | 2413 (20.77%) |
| With an alcohol-consuming history | 2196 | 130.38 ± 19.22 | 77.43 ± 10.23 | 52.95 ± 15.22 | 581 (26.46%) | 1014 (46.17%) | 371 (16.89%) | 154 (7.01%) | 40 (1.82%) | 601 (27.37%) |
| < 0.001 | < 0.001 | 0.084 | < 0.001 | < 0.001 | ||||||
HTN hypertension, BMI Body Mass Index, SBP Systolic Blood Press, DBP Diastolic Blood Pressure, PP Pulse Pressure.
Data are presented as n (%) or mean ± SD.
*Missing 38 cases.
Figure 1Blood pressure level by Sex and ethnicity. (a) By sex, (b) By ethnicity.
Age and sex-standardized prevalence, awareness, treatment, control of HTN for the study group, and age-standardized rates for men and women.
| Total (%) | Men (%) | Women (%) | |
|---|---|---|---|
| Prevalence | 15.80 | 16.59 | 14.96 |
| Awareness | 16.48 | 15.22 | 17.76 |
| Treatment | 11.99 | 10.11 | 13.91 |
| Control | 3.62 | 3.03 | 4.22 |
| Control among treated HTN patients | 23.56 | 17.98 | 16.33 |
Data are presented as n%; the standardized procedure was according to the data of the 2010 Population Census of the People's Republic of China.
Prevalence and control rate of HTN based on 2010 Chinese high blood pressure guideline and 2017 ACC/AHA high blood pressure guideline.
| Characteristics | Prevalence, n (%) | Control, n (%) | Control among treated HTN participants, n (%) | |||
|---|---|---|---|---|---|---|
| 2010 Chinese | 2017 ACC/AHA | 2010 Chinese | 2017 ACC/AHA | 2010 Chinese | 2017 ACC/AHA | |
| Total | 3014 (21.82%) | 5967 (43.20%) | 193 (6.40%) | 74 (1.24%) | 193 (25.03%) | 74 (9.60%) |
| 15–24 | 47 (2.63%) | 247 (13.82%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| 25–34 | 62 (2.65%) | 475 (20.26%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| 35–44 | 176 (6.75%) | 758 (29.09%) | 9 (5.11%) | 5 (0.66%) | 9 (42.86%) | 5 (23.81%) |
| 45–54 | 435 (20.04%) | 1023 (47.12%) | 29 (6.67%) | 14 (1.37%) | 29 (35.37%) | 14 (17.07%) |
| 55–64 | 684 (35.46%) | 1186 (61.48%) | 52 (7.60%) | 17 (1.40%) | 52 (27.37%) | 17 (8.95%) |
| 65–74 | 784 (50.13%) | 1157 (73.98%) | 56 (7.14%) | 22 (1.90%) | 56 (23.93%) | 22 (9.40%) |
| ≥ 75 | 826 (58.50%) | 1121 (79.39%) | 47 (5.69%) | 16 (1.43%) | 47 (19.26%) | 16 (6.56%) |
| < 0.001 | < 0.001 | 0.087 | 0.013 | 0.01 | 0.012 | |
| Men | 1412 (21.68%) | 3001 (46.08%) | 83 (5.88%) | 30 (1.00%) | 83 (26.69%) | 30 (9.65%) |
| Women | 1602 (21.94%) | 2966 (40.62%) | 110 (6.87%) | 44 (1.48%) | 110 (23.91%) | 44 (9.57%) |
| 0.713 | < 0.001 | 0.269 | 0.091 | 0.383 | 0.97 | |
| Han | 1324 (20.35%) | 2789 (42.87%) | 119 (8.99%) | 46 (1.65%) | 119 (29.38%) | 46 (11.36%) |
| Zhuang | 1627 (23.50%) | 3042 (43.94%) | 74 (4.55%) | 28 (0.92%) | 74 (20.33%) | 28 (7.69%) |
| Others | 63 (16.41%) | 136 (35.42%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| < 0.001 | 0.21 | < 0.001 | 0.013 | 0.004 | 0.085 | |
| < 24 | 1810 (17.73%) | 3828 (37.49%) | 107 (5.91%) | 43 (1.12%) | 107 (26.35%) | 43 (10.59%) |
| ≥ 24 | 1204 (33.42%) | 2139 (59.37%) | 86 (7.14%) | 31 (1.45%) | 86 (23.56%) | 31 (8.49%) |
| < 0.001 | < 0.001 | 0.176 | 0.275 | 0.371 | 0.323 | |
| Never attended school | 781 (47.97%) | 1127 (69.23%) | 51 (6.53%) | 18 (1.60%) | 51 (22.77%) | 18 (8.04%) |
| Elementary school | 1339 (31.54%) | 2399 (56.51%) | 82 (6.12%) | 32 (1.33%) | 82 (23.63%) | 32 (9.22%) |
| Elementary middle school | 705 (11.96%) | 1895 (32.15%) | 47 (6.67%) | 18 (0.95%) | 47 (30.13%) | 18 (11.54%) |
| High school or above | 176 (8.77%) | 524 (26.11%) | 12 (6.82%) | 5 (0.95%) | 12 (30.00) | 5 (12.50%) |
| < 0.001 | < 0.001 | 0.955 | 0.388 | 0.301 | 0.624 | |
| No family history | 2719 (21.53%) | 5404 (42.79%) | 153 (5.63%) | 61 (1.13%) | 153 (24.09%) | 61 (9.61%) |
| Family history | 295 (24.89%) | 563 (47.51%) | 40 (13.56%) | 13 (2.31%) | 40 (29.41%) | 13 (9.56%) |
| 0.007 | 0.002 | < 0.001 | 0.016 | 0.194 | 0.986 | |
| Non-smokers | 2404 (20.86%) | 4747 (41.20%) | 161 (6.70%) | 63 (1.33%) | 161 (25.00%) | 63 (9.78%) |
| Past smokers | 76 (48.72%) | 108 (69.23%) | 5 (6.58%) | 1 (0.93%) | 5 (19.23%) | 1 (3.85%) |
| Current smokers | 534 (25.01%) | 1112 (52.08%) | 27 (5.06%) | 10 (0.90%) | 27 (26.73%) | 10 (9.90%) |
| < 0.001 | < 0.001 | 0.374 | 0.488 | 0.733 | 0.598 | |
| No history of alcohol consumption | 2413 (20.77%) | 4776 (41.11%) | 157 (6.51%) | 65 (1.36%) | 157 (24.08%) | 65 (9.97%) |
| With an alcohol-consuming history | 601 (27.37%) | 1191 (54.23%) | 36 (5.99%) | 9 (0.76%) | 36 (30.25%) | 9 (7.56%) |
| < 0.001 | < 0.001 | 0.644 | 0.091 | 0.153 | 0.413 | |
HTN Hypertension, BMI Body Mass Index.
Data are presented as n (%).
*Missing 38 cases.
Awareness, treatment, and control of HTN by characteristics.
| Characteristics | Hypertension, n | Awareness, n (%) | Treatment, n (%) | Control, n (%) | Control among treated HTN participants, n (%) |
|---|---|---|---|---|---|
| Total | 3014 | 1005 (33.34%) | 771 (25.58%) | 193 (6.40%) | 193 (25.03%) |
| 15–24 | 47 | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| 25–34 | 62 | 2 (3.23%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| 35–44 | 176 | 31 (17.61%) | 21 (11.93%) | 9 (5.11%) | 9 (42.86%) |
| 45–54 | 435 | 113 (25.98%) | 82 (18.85%) | 29 (6.67%) | 29 (35.37%) |
| 55–64 | 684 | 242 (35.38%) | 190 (27.78%) | 52 (7.60%) | 52 (27.37%) |
| 65–74 | 784 | 295 (37.63%) | 234 (29.85%) | 56 (7.14%) | 56 (23.93%) |
| ≥ 75 | 826 | 322 (38.98%) | 244 (29.54%) | 47 (5.69%) | 47 (19.26%) |
| < 0.001 | < 0.001 | 0.087 | 0.01 | ||
| Men | 1412 | 430 (30.45%) | 311 (22.03%) | 83 (5.88%) | 83 (26.69%) |
| Women | 1602 | 575 (35.89%) | 460 (28.71%) | 110 (6.87%) | 110 (23.91%) |
| 0.002 | < 0.001 | 0.269 | 0.383 | ||
| Han | 1324 | 495 (37.39%) | 405 (30.59%) | 119 (8.99%) | 119 (29.38%) |
| Zhuang | 1627 | 508 (31.22%) | 364 (22.37%) | 74 (4.55%) | 74 (20.33%) |
| Others | 63 | 2 (3.17%) | 2 (3.17%) | 0 (0.00%) | 0 (0.00%) |
| < 0.001 | < 0.001 | < 0.001 | 0.004 | ||
| < 24 | 1810 | 542 (29.94%) | 406 (22.43%) | 107 (5.91%) | 107 (26.35%) |
| ≥ 24 | 1204 | 463 (38.46%) | 365 (30.32%) | 86 (7.14%) | 86 (23.56%) |
| < 0.001 | < 0.001 | 0.176 | 0.371 | ||
| Never attended school | 781 | 293 (37.52%) | 224 (28.68%) | 51 (6.53%) | 51 (22.77%) |
| Elementary school | 1339 | 442 (33.01%) | 347 (25.91%) | 82 (6.12%) | 82 (23.63%) |
| Elementary middle school | 705 | 207 (29.36%) | 156 (22.13%) | 47 (6.67%) | 47 (30.13%) |
| High school or above | 176 | 58 (32.95%) | 40 (22.73%) | 12 (6.82%) | 12 (30.00) |
| 0.011 | 0.027 | 0.955 | 0.301 | ||
| No family history | 2719 | 838 (30.82%) | 635 (23.35%) | 153 (5.63%) | 153 (24.09%) |
| Family history | 295 | 167 (56.61%) | 136 (46.10%) | 40 (13.56%) | 40 (29.41%) |
| < 0.001 | < 0.001 | < 0.001 | 0.194 | ||
| Non-smokers | 2404 | 822 (34.19%) | 644 (26.79%) | 161 (6.70%) | 161 (25.00%) |
| Past smokers | 76 | 34 (44.74%) | 26 (34.21%) | 5 (6.58%) | 5 (19.23%) |
| Current smokers | 534 | 149 (27.90%) | 101 (18.91%) | 27 (5.06%) | 27 (26.73%) |
| 0.002 | < 0.001 | 0.374 | 0.733 | ||
| No history of alcohol consumption | 2413 | 823 (34.11%) | 652 (27.02%) | 157 (6.51%) | 157 (24.08%) |
| With an alcohol-consuming history | 601 | 182 (30.28%) | 119 (19.80%) | 36 (5.99%) | 36 (30.25%) |
| 0.075 | < 0.001 | 0.644 | 0.153 | ||
HTN Hypertension, BMI Body Mass Index.
Data are presented as n (%).
*Missing 38 cases.
The usage of antihypertensive medications in the study group.
| Medication type | Total (n = 771) | Han (n = 405) | Zhuang (n = 364) | Men (n = 311) | Women (n = 460) |
|---|---|---|---|---|---|
| CCBs | 318 (41.25%) | 192 (47.41%) | 125 (34.34%) | 129 (41.48%) | 189 (41.09%) |
| ACEIs or ARBs | 82 (10.64%) | 35 (8.64%) | 47 (12.91%) | 32 (10.29%) | 50 (10.87%) |
| β-blockers | 26 (3.37%) | 3 (0.74%) | 22 (6.04%) | 15 (4.82%) | 11 (2.39%) |
| Diuretics | 12 (1.56%) | 8 (1.98%) | 4 (1.10%) | 7 (2.25%) | 5 (1.09%) |
| CCBs & ACEIs or ARBs | 22 (2.85%) | 10 (2.47%) | 12 (3.30%) | 7 (2.25%) | 15 (3.26%) |
| CCBs & β-blockers | 8 (1.04%) | 4 (0.99%) | 4 (1.10%) | 4 (1.29%) | 4 (0.87%) |
| CCBs & Diuretics | 5 (0.65%) | 3 (0.74%) | 2 (0.55%) | 3 (0.96%) | 2 (0.43%) |
| ACEIs or ARBs & β-blockers | 7 (0.91%) | 1 (0.25%) | 6 (1.65%) | 5 (1.61%) | 2 (0.43%) |
| ACEIs or ARBs & diuretics | 2 (0.26%) | 1 (0.25%) | 1 (0.27%) | 0 (0.00%) | 2 (0.43%) |
| β-blockers & diuretics | 1 (0.13%) | 0 (0.00%) | 1 (0.27%) | 0 (0.00%) | 1 (0.22%) |
| Triple-pill combinations | 3 (0.39%) | 3 (0.74%) | 0 (0.00%) | 2 (0.64%) | 1 (0.22%) |
| Others* | 285 (36.96%) | 145 (35.80%) | 140 (38.46%) | 107 (34.41%) | 178 (38.70%) |
| P value | < 0.001 | 0.272 | |||
CCBs Calcium Channel Blockers, ACEIs Angiotensin-Converting Enzyme Inhibitors, ARBs Angiotensin II Receptor Blockers.
Data are presented as n (%).
*Including traditional Chinese medications, not guideline-recommended medications, and medications with unknown components.
Figure 2Multiple factors of HTN for the study group.
Figure 3Risk factors of HTN for the Han and Zhuang nationalities.